Openbookopenbook
Equity
Applied DNA Sciences, Inc.(BNBX)
USD --+0.00%
Reward36Moderate
Risk51Moderate
📊75%Data
Revenue down 35% YoY
BNBX
+0.0 · +0.00%
USD · NASDAQ
Applied DNA Sciences, Inc. | Financial Services
Earnings Deterioration
Market Cap:2.90M
ℹ️
Reward Rating
36
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
51
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BNBX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Applied DNA Sciences, Inc.?

The company offers real-time data tracking of treasury performance and market indicators.

BNBX · Verdict

Limited reward · elevated risk

BNBX stands out on valuation and balance sheet, but watch the profitability signal.

Based on 88% data coverage

BNBX · Verdict

What’s working & what to watch

Strengths 3

  • Valuation70/100

    P/E 158.7× · PEG 1.27

  • Balance sheet70/100

    Current ratio 0.91

  • Volatility65/100

    Above average

Watchouts 3

  • Profitability14/100

    -709% net margin · -199% ROE

  • Cash flow20/100

    -600% free-cash-flow margin

  • Growth25/100

    Rev -51.0% CAGR · earnings +22.4%

Model-based scoring. For information only — not financial advice.

What is Applied DNA Sciences, Inc.?

The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company is listed on the NASDAQ in USA, operating in the Financial Services sector, with a market capitalisation of 2.90M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Performance tied to macro conditions — sensitive to interest rate cycles.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (36)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorFinancial Services
Market Cap2.90M
P/E Ratio0.0018
Dividend YieldN/A
52 Week High13.8
52 Week Low0.45
Last AnnualSeptember
IPO Date7/15/2003
IncorporatedUSA
Shares Outstanding6M
No. of Employees26
IndustryAsset Management
ExchangeNASDAQ
Beta0.696
CurrencyUSD
Websitewww.bnbx.io
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.